{"lastName":"van Berkel","objectUrn":"urn:li:member:9621932","geoRegion":"London, England, United Kingdom","fullName":"Patrick van Berkel","firstName":"Patrick","currentPositions":[{"companyName":"ADC Therapeutics","title":"Chief Scientific Officer","tenureAtCompany":{"numYears":1,"numMonths":8},"companyUrnResolutionResult":{"employeeCountRange":"201-500","headquarters":{"geographicArea":"Vaud, Switzerland","country":"Switzerland","city":"Lausanne"},"website":"http:\/\/www.adctherapeutics.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/adc-therapeutics\/","industry":"Biotechnology Research"},"startedOn":{"month":10,"year":2022},"companyUrn":"urn:li:fs_salesCompany:8297253"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAACS0awB4xq0AifJupW0VeJVuRPOwVn8mDw,NAME_SEARCH,vEtc)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1653416117055?e=1723075200&v=beta&t=dGGEGvyzV1KfYG9NbWPTASVrqrXHuIxbdWH7mG35394","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1653416117055?e=1723075200&v=beta&t=_e8YtMcyFdiphizEO0DiA5tG0uUsx6vaNjc9Latk58Y","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1653416117055?e=1723075200&v=beta&t=4dcjshfqdr91yyYQMVMmuu5f0xsStb3R40SGRZKp6HY","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1653416117055?e=1723075200&v=beta&t=jxYEs63cG_tvfBEww2MsoZ4ZG547pm0zSvTCxwtNUB4","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C4E03AQF2XcF7Dp0_cw\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":1991},"school":"urn:li:fs_salesSchool:6901","startedOn":{"year":1989},"schoolUrn":"urn:li:fs_salesSchool:6901","eduId":5986968},{"school":"urn:li:fs_salesSchool:13515","schoolName":"Hogeschool West Brabant","schoolUrn":"urn:li:fs_salesSchool:13515","eduId":17485732}],"skills":[{"numOfEndorsement":19,"name":"Biopharmaceuticals"},{"numOfEndorsement":25,"name":"Antibodies"},{"numOfEndorsement":10,"name":"CMC"},{"numOfEndorsement":16,"name":"Biotechnology"},{"numOfEndorsement":7,"name":"Monoclonal Antibodies"},{"numOfEndorsement":11,"name":"Drug Development"},{"numOfEndorsement":3,"name":"Drug Discovery"},{"numOfEndorsement":5,"name":"Technology Transfer"},{"numOfEndorsement":3,"name":"Lifesciences"},{"numOfEndorsement":7,"name":"Immunology"},{"numOfEndorsement":4,"name":"Cell Culture"},{"numOfEndorsement":8,"name":"Life Sciences"},{"numOfEndorsement":1,"name":"Pharmaceutical Industry"},{"numOfEndorsement":7,"name":"Protein Chemistry"},{"numOfEndorsement":1,"name":"Molecular Biology"},{"numOfEndorsement":6,"name":"GLP"}],"numOfConnections":1049,"patents":[],"headline":"ADC Therapeutics SA","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/patrick-van-berkel-2b82803","organizations":[],"location":"London, England, United Kingdom","publications":[],"positions":null,"posts":[{"createdAt":1716448980000,"insightId":"886432f7-c6b9-4448-aec8-565882cdc24b","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":14}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7199308919498756096","threadUrn":"urn:li:activity:7199308919498756096","reactionsCount":14,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7199308918890594304","message":{"attributes":[{"start":0,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/ejzCXviR"}}}],"text":"https:\/\/lnkd.in\/ejzCXviR"},"rootActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQHU4vtu2lQpkQ\/articleshare-shrink_800\/0\/1716406749040?e=1717977600&v=beta&t=Hhw6Qy5uQ65mgTiu2Dmov-IuFsBYJ9hfQ91vpzZDrTk","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQHU4vtu2lQpkQ\/articleshare-shrink_800\/0\/1716406749040?e=1717977600&v=beta&t=Hhw6Qy5uQ65mgTiu2Dmov-IuFsBYJ9hfQ91vpzZDrTk"}]},"description":"An antibody\u2013drug conjugate that targets the pan-haematopoietic marker CD45 combined with transplanted stem cells engineered to be shielded from it can eradicate leukaemic cells while preserving haematopoiesis.","resolvedUrl":"https:\/\/www.nature.com\/articles\/s41586-024-07456-3","title":"Selective haematological cancer eradication with preserved haematopoiesis - Nature"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7199136680904118273","message":{"attributes":[{"start":155,"length":16,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:7131"}}},{"start":191,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/e_EDy-ww"}}},{"start":481,"length":20,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:310088656"}}},{"start":503,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:321525047"}}},{"start":519,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:369663489"}}},{"start":532,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:1102734142"}}},{"start":549,"length":12,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:148369267"}}},{"start":563,"length":25,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:136567091"}}},{"start":590,"length":18,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:36829004"}}},{"start":610,"length":12,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:332131471"}}},{"start":651,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:177879035"}}},{"start":664,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:755080752"}}},{"start":680,"length":9,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:475659346"}}},{"start":691,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:458118658"}}},{"start":707,"length":10,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:607428803"}}},{"start":719,"length":17,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:219035412"}}},{"start":738,"length":24,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:690620406"}}},{"start":775,"length":18,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:9621932"}}},{"start":795,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:477683837"}}},{"start":829,"length":17,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:178964503"}}},{"start":867,"length":16,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:388980811"}}},{"start":885,"length":18,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:647873055"}}},{"start":905,"length":17,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:58177417"}}},{"start":924,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:202579242"}}},{"start":938,"length":19,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:10936"}}},{"start":959,"length":29,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:3061701"}}},{"start":990,"length":25,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:78708728"}}},{"start":1017,"length":19,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:71939371"}}},{"start":1038,"length":19,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:18419342"}}},{"start":1059,"length":16,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:8297253"}}}],"text":"Today, we are thrilled to share our approach to selectively eradicate haematological cancers while preserving healthy haematopoiesis, published in Nature (Nature Portfolio).\nFull story here: https:\/\/lnkd.in\/e_EDy-ww \n\nI have deep compassion for anyone who has suffered directly or indirectly from cancer and I hope this work will spark hope in the fight against blood cancers.\nThis achievement wouldn't have been possible without the invaluable contributions of many individuals:\n\nRomina Matter-Marone, Rosalba Lepore, Anna Devaux, Astrid Beerlage, Denis Seyres, Alessandro Dell'Aglio PhD, Darius Ju\u0161kevi\u010dius, Jessica Zuin, Thomas Burgold, Sisi Wang, Varun Katta, Garret Manquen, Yichao Li, Cl\u00e9ment Larrue, Anna Camus, Izabela Durzynska, Lisa Christina Wellinger, Ian Kirby, Patrick van Berkel, Christian Kunz, J\u00e9r\u00f4me Tamburini, Francesco Bertoni, Corinne C. Widmer, Shengdar Q. Tsai, Federico Simonetta, Stefanie Urlinger, Lukas Jeker.\n\nUniversity of Basel, H\u00f4pital Universitaire de B\u00e2le, Department of Biomedicine, Cimeio Therapeutics, Ridgeline Discovery, ADC Therapeutics."},"entityUrn":"urn:li:share:7199136680904118273"},"entityUrn":"urn:li:share:7199308918890594304"}}}]}